Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy

  • Technology appraisal guidance
  • TA378
  • Published: 

Do no do examples

Title Year published Impact Level
No results could be found